Literature DB >> 9126482

CD156 (human ADAM8): expression, primary amino acid sequence, and gene location.

K Yoshiyama1, Y Higuchi, M Kataoka, K Matsuura, S Yamamoto.   

Abstract

The murine cell-surface antigen MS2 [ADAM 8; mouse CD156 (mCD156)] is a transmembrane glycoprotein that is highly expressed in monocytic lineages. mCD156 consists of a long exterior region containing domains strikingly similar to those of hemorrhagic snake venom proteins. cDNA for human CD156 was isolated from cDNA libraries from the human macrophage cell line THP-1 and from human granulocytes. The CD156 cDNA detected mRNA from human macrophage cell lines, granulocytes, monocytes, and B cell but not T cell lines. The nucleotide sequence of the CD156 cDNA showed 65.6% homology with that of mCD156, and its amino acid sequence had high homology with hemorrhagic snake venom proteins and other related mammalian proteins. The CD156 gene was mapped to human chromosome 10q26.3.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9126482     DOI: 10.1006/geno.1997.4607

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  31 in total

1.  Expression of ADAMs ("a disintegrin and metalloprotease") in the human lung.

Authors:  Antoon Dijkstra; Dirkje S Postma; Jacobien A Noordhoek; Monique E Lodewijk; Henk F Kauffman; Nick H T ten Hacken; Wim Timens
Journal:  Virchows Arch       Date:  2009-03-03       Impact factor: 4.064

2.  A disintegrin and metalloprotease (ADAM) 10 and ADAM17 are major sheddases of T cell immunoglobulin and mucin domain 3 (Tim-3).

Authors:  Katja Möller-Hackbarth; Christin Dewitz; Olga Schweigert; Ahmad Trad; Christoph Garbers; Stefan Rose-John; Jürgen Scheller
Journal:  J Biol Chem       Date:  2013-10-11       Impact factor: 5.157

3.  Different proteolytic mechanisms involved in Fc gamma RIIIb shedding from human neutrophils.

Authors:  P J Middelhoven; J D Van Buul; P L Hordijk; D Roos
Journal:  Clin Exp Immunol       Date:  2001-07       Impact factor: 4.330

4.  Alpha9beta1: a novel osteoclast integrin that regulates osteoclast formation and function.

Authors:  Hongwei Rao; Ganwei Lu; Hiroshi Kajiya; Veronica Garcia-Palacios; Noriyoshi Kurihara; Judy Anderson; Ken Patrene; Dean Sheppard; Harry C Blair; Jolene J Windle; Sun Jin Choi; G David Roodman
Journal:  J Bone Miner Res       Date:  2006-10       Impact factor: 6.741

5.  Intervertebral Disc Degeneration in a Percutaneous Mouse Tail Injury Model.

Authors:  Zuozhen Tian; Xiaoyuan Ma; Miersalijiang Yasen; Robert L Mauck; Ling Qin; Frances S Shofer; Lachlan J Smith; Maurizio Pacifici; Motomi Enomoto-Iwamoto; Yejia Zhang
Journal:  Am J Phys Med Rehabil       Date:  2018-03       Impact factor: 2.159

6.  Deficiency of the metalloproteinase-disintegrin ADAM8 is associated with thymic hyper-cellularity.

Authors:  Klaus Gossens; Silvia Naus; Georg A Holländer; Hermann J Ziltener
Journal:  PLoS One       Date:  2010-09-15       Impact factor: 3.240

7.  Adam8 limits the development of allergic airway inflammation in mice.

Authors:  Martin D Knolle; Takahiro Nakajima; Anja Hergrueter; Kushagra Gupta; Francesca Polverino; Vanessa J Craig; Susanne E Fyfe; Muhammad Zahid; Perdita Permaul; Manuela Cernadas; Gilbert Montano; Yohannes Tesfaigzi; Lynette Sholl; Lester Kobzik; Elliot Israel; Caroline A Owen
Journal:  J Immunol       Date:  2013-05-13       Impact factor: 5.422

8.  High ADAM8 expression is associated with poor prognosis in patients with hepatocellular carcinoma.

Authors:  Yun Zhang; Yong-Fei Tan; Chao Jiang; Kai Zhang; Tian-Zhou Zha; Miao Zhang
Journal:  Pathol Oncol Res       Date:  2012-09-12       Impact factor: 3.201

9.  Influence of Genetic Background and Sex on Gene Expression in the Mouse (Mus musculus) Tail in a Model of Intervertebral Disc Injury.

Authors:  Julie M Brent; Zuozhen Tian; Frances S Shofer; John T Martin; Lutian Yao; Christian Acharte; Youhai H Chen; Ling Qin; Motomi Enomoto-Iwamoto; Yejia Zhang
Journal:  Comp Med       Date:  2020-03-10       Impact factor: 0.982

Review 10.  ADAM8: a new therapeutic target for asthma.

Authors:  Martin D Knolle; Caroline A Owen
Journal:  Expert Opin Ther Targets       Date:  2009-05       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.